Progress With BTK Inhibitors: A Journey Through the Mechanisms of Covalent and Noncovalent Options
HTML-код
- Опубликовано: 21 ноя 2021
- Chair, Nirav Shah, MD, MS, discusses B-cell cancers in this CME/MOC activity titled “Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/AMC865. CME/MOC credit will be available until November 18, 2022.
